BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL

被引：6

作者：

Sandhu, Roopinder K. ^{[1
]}

Ezekowitz, Justin ^{[1
]}

Andersson, Ulrika ^{[1
]}

Alexander, John ^{[1
]}

Granger, Christopher ^{[1
]}

Halvorsen, Sigrun ^{[1
]}

Hanna, Michael ^{[1
]}

Hijazi, Ziad ^{[1
]}

Jansky, Petr ^{[1
]}

Lopes, Renato ^{[1
]}

Wallentin, Lars ^{[1
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期

关键词：

D O I：

10.1016/S0735-1097(15)60284-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1270M-07

引用

页码：A284 / A284

页数：1

共 50 条

[1] History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
De Caterina, Raffaele
Andersson, Ulrika
Alexander, John H.
Al-Khatib, Sana M.
Bahit, M. Cecilia
Goto, Shinya
Hanna, Michael
Held, Claes
Hohnloser, Stefan
Hylek, Elaine M.
Lanas, Fernando
Lopes, Renato D.
Lopez-Sendon, Jose
Renda, Giulia
Horowitz, John
Granger, Christopher B.
Wallentin, Lars
[J]. AMERICAN HEART JOURNAL, 2016, 175 : 175 - 183
[2] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Garcia, David A.
Fisher, Deborah A.
Mulder, Hillary
Wruck, Lisa
De Caterina, Raffele
Halvorsen, Sigrun
Granger, Christopher B.
Held, Claes
Wallentin, Lars
Alexander, John H.
Lopes, Renato D.
[J]. AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
[3] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
Garcia, David A.
Wallentin, Lars
Lopes, Renato D.
Thomas, Laine
Alexander, John H.
Hylek, Elaine M.
Ansell, Jack
Hanna, Michael
Lanas, Fernando
Flaker, Greg
Commerford, Patrick
Xavier, Denis
Vinereanu, Dragos
Yang, Hongqiu
Granger, Christopher B.
[J]. AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
[4] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Avezum, Alvaro
Lopes, Renato D.
Schulte, Phillip J.
Lanas, Fernando
Gersh, Bernard J.
Hanna, Michael
Pais, Prem
Erol, Cetin
Diaz, Rafael
Cecilia Bahit, M.
Bartunek, Jozef
De Caterina, Raffaele
Goto, Shinya
Ruzyllo, Witold
Zhu, Jun
Granger, Christopher B.
Alexander, John H.
[J]. CIRCULATION, 2015, 132 (08) : 624 - 632
[5] Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Granger, Christopher B.
Lopes, Renato D.
Hanna, Michael
Ansell, Jack
Hylek, Elaine M.
Alexander, John H.
Thomas, Laine
Wang, Junyuan
Bahit, M. Cecilia
Verheugt, Freek
Lawrence, Jack
Xavier, Denis
Wallentin, Lars
[J]. AMERICAN HEART JOURNAL, 2015, 169 (01) : 25 - 30
[6] Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
Lopes, Renato D.
Alexander, John H.
Al-Khatib, Sana M.
Ansell, Jack
Diaz, Raphael
Easton, J. Donald
Gersh, Bernard J.
Granger, Christopher B.
Hanna, Michael
Horowitz, John
Hylek, Elaine M.
McMurray, John J. V.
Verheugt, Freek W. A.
Wallentin, Lars
[J]. AMERICAN HEART JOURNAL, 2010, 159 (03) : 331 - 339
[7] Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Goto, Shinya
Zhu, Jun
Liu, Lisheng
Oh, Byung-Hee
Wojdyla, Daniel M.
Aylward, Philip
Bahit, M. Cecilia
Gersh, Bernard J.
Hanna, Michael
Horowitz, John
Lopes, Renato D.
Wallentin, Lars
Xavier, Denis
Alexander, John H.
[J]. AMERICAN HEART JOURNAL, 2014, 168 (03) : 303 - 309
[8] The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
Sandhu, Roopinder K.
Ezekowitz, Justin
Andersson, Ulrika
Alexander, John H.
Granger, Christopher B.
Halvorsen, Sigrun
Hanna, Michael
Hijazi, Ziad
Jansky, Petr
Lopes, Renato D.
Wallentin, Lars
[J]. EUROPEAN HEART JOURNAL, 2016, 37 (38) : 2869 - 2878
[9] APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL
Cowper, Patricia A.
Pan, Wenqin
Anstrom, Kevin
Stafford, Judith
Lopes, Renato
Davidson-Ray, Linda
Wallentin, Lars
Phatak, Hemant
Ansell, Jack
Dorian, Paul
Husted, Steen
McMurray, John
Steg, P. Gabriel
Alexander, John
Granger, Christopher
Mark, Daniel
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1576 - E1576
[10] Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Westenbrink, B. Daan
Alings, Marco
Granger, Christopher B.
Alexander, John H.
Lopes, Renato D.
Hylek, Elaine M.
Thomas, Laine
Wojdyla, Daniel M.
Hanna, Michael
Keltai, Matyas
Steg, P. Gabriel
De Caterina, Raffaele
Wallentin, Lars
van Gilst, Wick H.
[J]. AMERICAN HEART JOURNAL, 2017, 185 : 140 - 149

← 1 2 3 4 5 →